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ABSTRACT  
The present research work aims to fabricate and optimize gastroretentive floating mucoadhesive tablets of Cefpodoxime Proxetil, so as to 
remain in the gastric region for appropriate hours and hence significantly prolong the gastric residence time of drugs which improve 
bioavailability. Floating-Mucoadhesive tablets of Cefpodoxime Proxetil were prepared by direct compression method using various polymers 
such as HPMC K 200 M, Carbopol 940P. Sodium Bicarbonate & Citric acid was incorporated as a gas-generating agents and HPMC K 200 M, 
Carbopol 940 P was incorporated as Mucoadhesive agent. Optimization study was carried out by using 32 factorial design. The concentration of 
polymers was considered as independent variables whereas Floating lag time,Swelling Index, Mucoadhesive Strength, of the tablets were 
utilized as dependent variables. The floating- Mucoadhesive tablets were evaluated for weight variation, hardness, thickness, friability, drug 
content, in-vitro buoyancy study, and in-vitro and ex-vivo Mucoadhesive studies, swelling index and in-vitro dissolution studies. The study 
reveals the significant effect of the amount of polymers on Floating lag time, Swelling Index, Mucoadhesive Strength of the tablets. FTIR, DSC 
study indicates no drug-excipients interaction in the prepared formulations. The prepared tablets exhibited satisfactory physico-chemical 
characteristics. All prepared batches shown good in-vitro buoyancy studies and Mucoadhesion studies. The In-vitro dissolution profiles of 
optimized floating- Mucoadhesive formulation of Cefpodoxime Proxetil were found to sustained the drug release up to 12 hrs and release can 
be extended for longer period over 12 hrs by increasing the concentration of polymers. The best result from optimized batches is of AT5 which 
gives floating lag time 21±2, Mucoadhesive strength 16.60 gm & drug release 98.65% in 12 hrs. Floating- Mucoadhesive tablet were prepared 
and could be a promising approach to deliver  Cefpodoxime Proxetil with improved gastric residence time which improve bioavailability &  
effective in the management of the bacterial infection.  
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INTRODUCTION 
Dosage form means suitable form of administration of drug. 
Oral drug administration has been the most convenient and 
preferable route for drug delivery [1]. When a drug is 
delivered as a conventional dosage form such as a tablet, the 
dosing interval is much shorter than the half-life of the drug 
resulting in a number of limitation like the fluctuating drug 
levels, A typical peak-valley plasma concentration-time 
profile, Poor patient compliance; increased chances of 
missing the dose of a drug with short half-life for which 
frequent administration is necessary so leads in to poor 
patient compliancen [2]. In order to overcome the drawbacks 
of conventional drug delivery systems there is need of novel 
drug delivery like gastrointestinal drug deliveryn [3,4]. 
Gastro retentive drug delivery system plays a vital role 
among novel drug delivery systemsn [5]. The retention of 
oral dosage forms in the upper GIT causes prolonged contact 
time of drug with the GI mucosa, leading to higher 
bioavailability, and hence therapeutic efficacy, reduced time 
intervals for drug administration, potentially reduced dose 
size and thus patient compliancen [6,7]. Over the last two 
decades, numbers of GRDDS have been designed to prolong 
GRT. The main aim of preparing GRDDS is to minimize the 
problem associated with existing oral sustained release 
dosage form and to develop patient benefited drug deliveryn 
[8,9]. 
Gastro retentive systems can remain in the gastric region for 
several hours and hence significantly prolong the gastric 
residence time of drugs which improve bioavailability, 
reduce drug waste, and improve solubility of drugs that are 
less soluble in a high pH environment. Floating & 
Mucoadhesion are two mostly used approach of GRDDSn 
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[10]. These GRDDS approaches have some advantages & 
disadvantages [10,11] . 
Floating system- Requirement of sufficient amount fluid in 
stomach as the stomach empties the tablet is at the pylorus, 
so the buoyancy of the dosage form affected & Mucoadhesive 
system- The tablet is detached from mucosa wall due to an 
effect of mucous turn over [12]. 
These disadvantages of individual approach of GRDDS can be 
overcome by making the floating system eventually adhere 
to the mucous lining of stomach wall. Thus floating and 
Mucoadhesive drug delivery system, thus, offers the 
advantage of increased gastric residence time of drugs over 
normal floating drug delivery system [13]. 
 Cefpodoxime Proxetil is third generation cephalosporin 
antibiotic, it is a prodrug. It is active against most Gram 
positive and Gram negative organisms [14]. It has an oral 
bioavailability of only 50% and biological half life 2 hrs by 
enhanced gastric retention time of Cefpodoxime Proxetil in 
floating Mucoadhesive dosage form will increase its 
absorptionn [15]. The present study involves the aims to 
fabricate and optimize gastroretentive mucoadhesive tablets 
of cefpodoxime proxetil , so as to remain in the gastric region 
for several hours and hence significantly prolong the gastric 
residence time of drugs which improve bioavailability. 
MATERIALS AND METHODS: 
Materials: Cefpodoxime Proxetil was obtained as gift sample 
from Swami Samarth Ayurvedic Pharmacy Jalgaon 
(Alopatheics division). HPMCK 200M, Carbopol 940, Sodium 
Bicarbonate, Citric Acid , Magnesium stearate, Citric Acid 
,and Lactose was Purchased from Research Lab Fine Chem. 
Ltd. Mumbai. All other ingredients used were of analytical 
grade. 
Drug& DSC- Excipient Compatibility Study: 
FTIR & DSC studies were conducted to know the 
compatibility between drug and excipients. 
a) FTIR 
FT-IR spectra for pure Cefpodoxime Proxetil and Different 
polymers acquired at room temperature using FT-IR 
spectrophotometer (FTIR-8400S, Shimadzu, Japan) in 
transmittance mode. The samples were ground in a mortar, 
mixed with Nujol and placed between two plates of KBr and 
compressed to form a thin film. The sandwiched plates were 
placed in the infrared spectrometer and the spectra were 
obtained. Scanning was performed between wave numbers 
4000-400 cm-1.. 
b) Differential Scanning Colorimetry Analysis 
Method for estimating the physical interaction between drug 
and polymers used for the formulation of different dosage 
form is thermal analysis by DSC. In the present studies the 
DSC analysis of drug, and Polymers were carried out using a 
Shimadzu DSC 60, Japan; to evaluate any possible polymer 
drug thermal interaction. Exactly weighed 5 to 6 mg samples 
were hermetically sealed in aluminium crucible and heated 
at constant rate of 10oC/min over a temperature range of 40 
to 300oC. Inert atmosphere was maintained by purging 
nitrogen gas at a flow rate of 50 ml/min. 
METHODS: 
Fabrication of Floating-Mucoadhesive Tablets [16,17,18]  
All the floating‐mucoadhesive tablets were fabricated by 
using direct compression technique. Drug and HPMC K 200 
M, Carbopol 940 and excipients were blended 
homogeneously in mortar. Blended mixture was passed 
through Sieve 60, finally Sodium bicarbonate, citric acid  and 
magnesium stearate was added and blended. The 
homogeneously blended mixture was compressed in rotary 
tablet press with the 09 mm rounded punch.  
Optimization by using full factorial designs [19] 
In the present study, a 32 full factorial design was employed 
to study the effect of independent variables, i.e. amount of … 
HPMCK 200 M …(X1) and… CARBOPOL 940… (X2) on 
dependent variables i.e. Floating lag time ,% Swelling index 
and Mucoadhesive Strength. 
Table 1: Layout of 32 full factorial design batches of 
floating Mucoadhesive Tablets AT1-AT9 
Batch No. X1 X2 
AT1 -1 -1 
AT2 -1 0 
AT3 -1 1 
AT4 0 -1 
AT5 0 0 
AT6 0 1 
AT7 1 -1 
AT8 1 0 
AT9 1 1 
 
Table 2: Translation of coded value in an actual unit 
Coded value 
HPMCK 200 M 
(X1)) 
CARBOPOL 
940(X2) 
-1 40 20 
0 50 30 
1 60 40 
 
Table 3:  Composition of Optimization batches AT1-AT9 
 
Ingredients (mg) 
 
Formulation batch code  
AT1 AT2 AT3 AT4 AT5 AT6 AT7 AT8 AT9 
Cefpodoxime Proxetil  100 100 100 100 100 100 100 100 100 
 HPMC K-200 M 40 40 40 50 50 50 60 60 60 
 Carbapol 940 20 30 40 20 30 40 20 30 40 
 Sodium bicarbonate 40 40 40 40 40 40 40 40 40 
 Citric acid 10 10 10 10 10 10 10 10 10 
Magnesium  stearate 7 7 7 7 7 7 7 7 7 
   Talc  5 5 5 5 5 5 5 5 5 
  Lactose  Q.S. QS QS QS QS QS QS QS QS QS 
 Total 300 300 300 300 300 300 300 300 300 
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Evaluation of farbricated  Floating Mucoadhesive tablets 
Tablets [20-28] 
All prepared sustained release tablets were evaluated for the 
following official & unofficial parameters. 
Thickness 
Thickness was measured using a vernier caliper. Five tablets 
of the formulation were picked randomly and thickness was 
measured individually.  
Hardness 
Hardness was measured using Monsanto hardness tester. 
The hardness expressed in kg/cm2. For each batch three 
tablets were tested.  
Friability 
Twenty tablets were weighed and placed in the Roche 
friabilator and apparatus was rotated at 25 rpm for 4 
minutes. After revolutions, the tablets were deducted and 
weighed again. The percentage friability was measured using 
formula,  
% F = {1-(Wt. /W)} ×100 …..                                (1) 
Where, % F = Friability in percentage  
W = Initial weight of tablets  
Wt. = Weight of tablets after revolution  
 
Weight variation 
Twenty tablets were randomly selected from each batch and 
individually weighed. The average weight and standard 
deviation of 20 tablets was calculated. The batch passes the 
test for weight variation test if not more than two of the 
individual tablet weight deviate from the average weight. 
Drug Content Uniformity 
Ten tablets for each batch was taken and triturated. Powder 
equivalent to dose of drug was weighed and was transferred 
to breaker and 0.1N HCl was added and it was then shaken 
for 5 min and finally 0.1N HCl was added to make the volume 
up to 100 ml and solution was then sonicated for 15 min and 
filtered through Whatman filter paper. Finally, a solution was 
diluted suitably and the absorbance of the resultant solution 
was measured to determine the drug content 
spectrophotometrically at 258 nm using UV/Visible 
spectrophotometer Shimadzu 1800 against 0.1N HCl blank. 
In-Vitro Buoyancy Studies 
The in-vitro buoyancy was determined by floating lag time. 
The time required for the tablet to rise to the surface and 
float was determined as floating lag time. In this the tablets 
were placed in 100 ml beaker containing 0.1 N HCL. 
Wash off Detachment time  
The mucoadhesive properties of the tablets were evaluated 
by an in vitro Mucoadhesion testing method known as wash 
off method. Pieces of stomach mucosa were mounted on the 
glass slides were connected with suitable support. About 2 
tablets attached on the glass slide & support was hung on the 
arm of USP tablet disintegration apparatus was given as slow 
regular up & down movement in 0.1 N HCL at 370C. The time 
of detachment of both the tablets was noted down. 
Mucoadhesive Strength test  
Mucoadhesive strength of the tablets were measured on the 
modified physical balance. The apparatus consist of a 
modified double beam physical balance in which the right 
pan has been replaced by a glass slide with copper wire and 
additional weight, to make the right side weight equal with 
left side pan. A taflon block of 3.8 cm diameter and 2 cm 
height was fabricated with an upward portion of 2 cm height 
and 1.5 cm diameter on one side. This was kept in beaker 
filled with buffer media 0.1N HCl pH 1.2, which was then 
placed below right side of the balance.  
Goat stomach mucosa was used as a model membrane and 
buffer media 0.1N HCl pH 1.2 was used as moistening fluid. 
The goat stomach mucosa was obtained from local slaughter 
house and kept in a Krebs buffer during transportation. The 
underlying mucous membrane was separated using surgical 
blade and wash thoroughly with buffer media 0.1N HCl pH 
1.2. It was then tied over the protrusion in the Teflon block 
using a thread. The block was then kept in glass beaker. The 
beaker was filled with 0.1N HCl pH 1.2 up to the upper 
surface of the goat stomach mucosa to maintain stomach 
mucosa viability during the experiments. The one side of the 
tablet was attached to the glass slide of the right arm of the 
balance and then the beaker was raised slowly until contact 
between goatmucosa and mucoadhesive tablet was 
established. A preload of 10 mg was placed on the slide for 
15 min (preload time) to established adhesion bonding 
between mucoadhesive tablet and goat stomach mucosa. The 
preload and preload time were kept constant for all 
formulations. After the completion of preload time, preload 
was removed from the glass slide and water was then added 
in the plastic bottle in left side arm by peristaltic pump at a 
constant rate of 100 drops per min. The addition of water 
was stopped when mucoadhesive tablet was detached from 
the goatstomach mucosa. The weight of water required to 
detach mucoadhesive tablet from stomach mucosa was noted 
as Mucoadhesive strength in grams. Mucoadhesion strength 
was determined in terms of force required to detach the 
tablet from the membrane. Mucoadhesive strength (F) was in 
terms of the weight in grams required to detach the tablet 
from the membrane. The tests were repeated in triplicate for 
each formulation. 
 
Force of adhesion (N) =     Mucoadhesive Strength                           
                                                             1000                                                     (2) 
Swelling Index Study 
The extent of swelling can be measured in terms of % weight 
gain by the tablet. For each formulation batch, one tablet was 
weighed and placed in a beaker containing 200 ml of buffer 
media. After each interval the tablet was removed from 
beaker and weighed again up to 12 h. The swelling index was 
calculated using following formula.  
Swelling index (S.I) = {(wt-wo) /WO} ×100 
Where, S.I. = Swelling index 
Wt. = Weight of tablet at time t 
WO = Weight of tablet before placing in the Beaker.  
                                            
In Vitro Dissolution Studies 
In-vitro drug release studies of the prepared floating tablets 
were conducted for a period of 12 hrs. Using USP type II 
apparatus (paddle) at 37± 0.5°C and at 100 rpm speed at pH 
1.2. After withdrawing, the samples were analysed by a UV 
spectrophotometer at 258nm. 
 
X  9.81 
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Data Analysis 
To analyse the mechanism of release and release rate 
kinetics of the dosage form, the data obtained were fitted 
into Zero order, First order, Higuchi matrix, Pappas and 
Hixson Crowell model using PCP-DISSO – v3 software. Based 
on the R-value, the best-fit model was selected. 
 
 
RESULTS AND DISCUSSION: 
FT-IR Study of Drug 
FTIR analysis of Cefpodoxime Proxetil  (Pure drug), 
Polymers & blend 
The IR spectrum of pure drug was found to be similar to the 
reference standard IR Spectrum of Cefpodoxime Proxetil 
given in Indian pharmacopoeia. The IR Spectrum of 
Cefpodoxime Proxetil shown in figure 1. 
 
 
Fig. 1: FTIR spectrum of Cefpodoxime Proxetil (Pure drug) 
 
Fig. 2: FTIR analysis of HPMC K 200M 
 
Fig. 3: FTIR analysis of Carbopol 
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Fig. 4: FTIR analysis of Cefpodoxime Proxetil with HPMC K 200M 
 
 
Fig. 5: FTIR spectrum of Cefpodoxime Proxetil with Carbopol 
 
 
Fig. 6: FTIR spectrum of blend (Cefpodoxime Proxetil+HPMC K 200M + Cabopol+Exicipient  in mixture ) 
 
Compatibility studies of pure drug Cefpodoxime Proxetil 
with polymers were carried out prior to the preparation of 
tablets. IR spectra of pure drug Cefpodoxime Proxetil and 
that of with polymers were obtained, which are shown in 
figure 2 to figure 6.All the characteristic peaks of 
Cefpodoxime Proxetil were present in spectra thus 
indicating compatibility between drug & excipients. It shows 
that there was no significant change in the chemical integrity 
of the drug. 
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DSC analysis ofCefpodoximeProxetil (Pure drug) & blend 
 
Fig. 7: DSC analysis of Cefpodoxime Proxetil ( Pure drug) 
  The DSC thermogram of Cefpodoxime Proxetil Fig.8 exhibited a single sharp endothermic peak at 1100C and, related to its 
melting point. 
 
Fig.8: DSC analysis of blend (Cefpodoxime Proxetil+HPMC K 200M + Cabopol+Exicipient in mixture) 
 
Studies were carried out using DSC 60, having TA60 
software, shimadzu, and Japan. Accurately weight sample 
were placed on aluminum plate, sealed with aluminum lid 
and heated at a constant rate 5 0C/min over a temperature 
rang 0 to 250 0C. Cefpodoxime Proxetil shown in figure 8.
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Evaluation of Fabricated Floating Mucoadhesive Tablets: 
Table 4:Post-compression parameter of factorial designed batches 
 
Formulation 
 
Thickness (n=3) 
(mm)(SD) 
 
Hardness 
(kg/cm2) 
(n=3)(SD) 
 
Friability 
(%) 
(n=3) 
 
 
Weight 
Variation 
(n=20)(mg) 
(SD) 
 
Drug Content 
(%) 
AT1 3.8±0.05 4.6±0.15 0.62±0.06 
301.55 
± 0.58 
99.55± 0.8 
AT2 3.7± 0.47 4.5± 0.40 
0.52±0.06 
 
298.7 
± 6.2 
96.18± 0.2 
AT3 4.0 ± 04 4.2 ± 0.6 0.55±0.09 
300.85 
± 5.2 
97.53± 0.6 
AT4 4.1 ± 0.2 4.6± 0.2 0.67±0.04 
300.9± 6.2 
 
98.35± 0.3 
AT5 4.3± 0.1 4.7± 0.1 0.59±0.04 
298.55 
± 5.3 
99.89± 0.6 
AT6 4.2± 0.1 4.4± 0.3 0.45±0.03 
304.2 
± 1.3 
97.11± 0.9 
AT7 4.5±0.3 3.9 ± 0.11 0.52 ±0.04 
303.85 
± 1.4 
101.4± 0.5 
AT8 3.8±0.26 4.3±0.28 0.46±0.02 
301.8 
± 6.09 
99.27± 0.6 
AT9 4.7 ± 0.1 3.9 ± 0.2 0.58±0.05 
302.15 
± 5.7 
96.06± 0.4 
 
Shape and Appearance 
All Formulations were prepared well and select randomly 
and picked from each batch examined under lens for shape 
and in presence of light for color. Tablets showed standard 
concave surfaces with circular shape. Tablets were white in 
color. 
Uniformity of Thickness 
Thickness of the tablets was measured using vernire calipers 
by picking three tablets randomly from all the batches. The 
thickness of all the factorial designed batches tablets was 
found within the range of 3.7± 0.47 to 4.7 ± 0.1mm. 
The results of thickness for tablets are shown in Table 4. 
Weight Variation Test 
The weight variation of the all formulations is shown in 
Table 4. All the tablets passed the weight variation test, i.e., 
average percentage weight variation was found within the 
pharmacopoeia limits of ±10%. 
Hardness Test 
Hardness of the tablets found within the range of 3.9 ± 
0.11Kg/cm2 to 4.7± 0.1for batch AT1 to AT9 .  
Friability Test 
Friability values of Tablet for optimized batch AT1, AT2, 
AT3, AT4, AT5, AT6, AT7, AT8, AT9 were found 0.62±0.06, 
0.52±0.06 %, 0.55±0.09%, 0.67±0.04%, 0.59±0.04%, 
0.45±0.03%, 0.52 ±0.04%, 0.46±0.02% and 0.58±0.05% 
respectively. The obtained results were found to be well 
within the approved range (<1%) in all the designed 
formulations. That indicated tablets possess good 
mechanical strength. The results are tabulated in Table 4. 
Drug Content 
The drug content uniformity was examined as per I.P 
specification. All the batches of tablets were found to comply 
with uniformity of content test and results are mentioned in 
Table 4. 
 
Table 5:In-vitro buoyancy study of optimized batches 
Formulation Codes Floating lag time(Sec) Total FLT( Hrs) 
AT1 23±2 >9 
AT2 19±1 >10 
AT3 33±4 >11 
AT4 29±2 >12 
AT5 21±2 >12 
AT6 26±3 >12 
AT7 41±2 >12 
AT8 36±4 >12 
AT9 42±4 >12 
 
All tablets of each batch floated well and floating lag time observed in between 19±1and 42±4 Sec. Total floating time for all 
batches observes minimum more than 9 hrs. 
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Fig. 9: A response surface plot showing effect of concentration of independent variables on the floating lag time 
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Fig. 10: A counter plot showing effect of concentration of independent variables on the floating lag time 
 
Mathematical relationship in the form of polynomial equation for the measured response floating lag time was obtained and 
given in equation below . 
 
Floating lag time(  Sec) =  +20.90                ….. (3) 
 +7.33   * A 
 +1.33   * B 
 -2.25   * A * B 
 +6.86   * A2 
 +6.86   * B2  
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Table 6: Wash off Test – (Optimized Batches) Detachment time 
Formulation code Sr. No. of tablet Detachment time (min) Average 
AT1 1 218 212 
2 207 
AT 2 1 234 237 
2 241 
AT 3 1 261 257 
2 254 
AT 4 1 270 278 
2 287 
AT 5 1 296 305 
2 304 
AT 6 1 319 337 
2 355 
AT 7 1 378 370 
2 363 
AT 8 1 396 401 
2 407 
AT 9 1 428 423 
2 419 
 
Table 7:Ex-vivo Mucoadhesion measurement, Swelling Index of optimized batches 
Formulation 
batch code 
Mucoadhesion 
strength (gm.) 
Force of  
Adhesion 
(dyne/cm2) 
Swelling index (%) 
AT1 7.84 0.78 123.17 
AT2 8.91 0.89 130.44 
AT3 11.96 1.19 136,2 
AT4 13.70 1.37 142.81 
AT5 16.60 1.66 154.40 
AT6 17.65 1.76 158.17 
AT7 18.58 1.85 160.18 
AT8 20.06 2.06 181.12 
AT9 22.03 2.2 184.22 
        
Ex-Vivo Mucoadhesion Measurement  
All the batches show good Detachment time & mucoadhesive strength.  
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Fig. 11: A response surface plot showing effect of concentration of independent variables on the Mucoadhesive 
strength 
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Fig. 12: A counter plot showings effect of concentration of independent variables on the Mucoadhesive strength 
Mathematical relationship in the form of polynomial equation for the measured Mucoadhesive strength was obtained and given 
in equation below. 
  Mucoadhesive strength =+16.2+4.04   * A+1.9 * B      ….. (4) 
 
Fig. 13: % Swelling Index of Optimized batches in graphical presentation 
Swelling index of all batches shown figure 13 i.e. AT1 to AT9 
is 123.17%, 130.44%, 136.2%, 142.81%, 154.40%, 158.17%, 
160.18%, 181.12% and 184.22% respectively 
The swelling ability of the tablets could be attributed to the 
existence of hydrophilic moieties on both HPMC K 200M. 
From the plots it as from the Figure 2 and 3, it was concluded 
that the SI increases with increasing polymer concentrations. 
Previously it was reported that matrix containing Lactose 
exhibited higher water uptake than those containing the 
other excipients Bamiro et al. [26] 
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Fig. 14: A response surface plot showing effect of concentration of independent variables on the swelling Index 
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Figure 23: Fig. 15: A counter plot showing effect of concentration of independent variables on the swelling Index 
Mathematical relationship in the form of polynomial equation for the measured Swelling Index was obtained and given in 
equation below. 
 
 Swelling Index =+154.53                                           ….. (5) 
+22.6* A 
+8.7* B 
+2.75* A * B 
+0.93* A2 
-4.36* B2 
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Result of ANOVA 
Table 8: Result of ANOVA 
Response 
model 
Sum of 
square 
Degree of 
freedom 
Mean 
square 
F value P value R square Ade. 
Precision 
Floating Lag 
time 
802.31 5 158.83 37.94 <0.0001 0.9644 16.35 
Mucoadhesive 
strength(gm) 
151.68 
 
2 65.29 
 
19.16 
 
0.0004 
 
0.8931 
 
14.017 
 
Swelling 
Index (%)) 
3638.33 
 
5 726.15 193.1 
 
<0.0001 0.9928 
 
47.737 
 
  
In-Vitro Drug Release Study of Optimized Batches 
 
Fig. 16: % Drug release of Optimized batches AT1-AT9 
The In-vitro drug release studies of factorial batches were carried out using USP Type II dissolution assembly. The drug release 
batch AT1, AT2, AT3, AT4, AT5, AT6, AT7, AT8 and AT9 were found 100.22%, 99.23%, 100.17%, 98.59%, 98.65%, 95.49%, 
92.16%, 89.53%, and 87.07% respectively.  
Data Analysis 
In vitro Drug release data Analysis 
 
Fig. 17: Release Profile of optimized batch (AT5) 
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Kinetic analysis of dissolution data optimized batch (AT5) 
Zero orderEquation: 
 
Fig. 18: Zero order equation for optimized batch (AT5) 
                
Korsmeyer-Peppas: 
 
Fig. 19:  Korsmeyer-Peppas equation for optimized 
batch (AT5)
 
Table 9: Mathematical Modeling and Release Kinetics of optimized batches 
Batch Zero order First order Higuchi Hixson- Crowell Korsmeyer-Peppas 
       F5 r2 K0(h
-1) r2 K1(h
-1) r2 KH (h
-1/2
)
 
 
r2 KHC (h
- 1/3
)
 r2 n KKP(h
-n) 
 0.9955 
 
8.3588 
 
0.8438 
 
 
-0.2205 
 
 
0.9116 
 
  
23.5558 
 
0.9295 
 
  
-0.0486 
 
 
 
0.9896 
 
0.9449 9.1279 
 
 
* 
r2= Correlation coefficient; K = Kinetic constant; n= Diffusional exponent 
 
When the regression coefficient ‘r’ value of Zero order and 
korsmeyer-peppas plots were compared, it was observed 
that the ‘r’ values of Zero order was found to be 0.9955 
whereas the ‘r’ values of korsmeyer-peppas plot was found 
to be 0.9896 indicating drug release from optimized 
formulation was found to follow Korsmeyer-peppas kinetics.  
The in-vitro dissolution data was fitted to Korsmeyer-
equation, values of exponent ‘n’ was found to be 0.9449 
indicating that the drug release is by Anomalous transport 
mechanism.   
CONCLUSIONS: 
Floating-Mucoadhesive tablets of Cefpodoxime Proxetil were 
prepared by direct compression method using various 
polymers such as HPMC K 200 M, Carbopol 940P. Sodium 
Bicarbonate & Citric acid was incorporated as a gas-
generating agents .  
The prepared tablets exhibited satisfactory physico-chemical 
characteristics. All prepared batches shown good in-vitro 
buoyancy studies and Mucoadhesion studies. The best result 
from optimized batches is of AT5 which gives floating lag 
time 21±2, Mucoadhesive strength 16.60 gm & drug release 
98.65% in 12hrs. Optimized formulation AT5 showed Zero 
order as best fit model having R2 value is 0.9955.. Floating- 
Mucoadhesive tablet were prepared and could be a 
promising approach to deliver  Cefpodoxime Proxetil with 
improved gastric residence time which improve bioavaibility 
&  effective in the management of the bacterial infection.  
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